Karus Therapeutics Ltd.

Investment area
Novo Ventures
Region
Europe
Date of investment
June 2012

Karus Therapeutics develops innovative therapies for the treatment of inflammation and cancer. The lead programmes are in pre-clinical development and focus on histone deacetylase and phosphoinositide 3-kinase inhibitors.

Karus Therapeutics Ltd.

Investment area
Novo Ventures
Region
Europe
Date of investment
June 2012

Karus Therapeutics develops innovative therapies for the treatment of inflammation and cancer. The lead programmes are in pre-clinical development and focus on histone deacetylase and phosphoinositide 3-kinase inhibitors.

Karus Therapeutics Ltd.

Investment area
Novo Ventures
Region
Europe
Date of investment
June 2012

Karus Therapeutics develops innovative therapies for the treatment of inflammation and cancer. The lead programmes are in pre-clinical development and focus on histone deacetylase and phosphoinositide 3-kinase inhibitors.